Table 1 Demographic, hematological, and blood cell count-derived inflammation indexes of COVID-19

Age

-

69.27 ± 12.90

Sex

-

 Male, N (%)

 Female, N (%)

98 (58)

71 (42)

Hospitalization stay

-

8.49 ± 6.97

WBC (×10⁹/L)

3.5–9.5

7.40 (4.90–10.80)

Adjusted WBC (×10⁹/L)

8.45 ± 0.07

Adjusted Neutrophil (×10⁹/L)

1.8–6.3

6.62 ± 0.91

Adjusted Lymphocyte (×10⁹/L)

1.1–3.2

1.41 ± 0.82

Adjusted Monocyte (×10⁹/L)

0.2–0.3

0.27 ± 0.17

Hb (mg/ml)

11.5–15

13.27 ± 2.46

Hct (%)

36–48

40.53 ± 7.12

PLT (×10⁹/L)

125–350

189 (145–250)

Adjusted Plt

125–350

202.28 ± 11.89

PT (s)

11-13.5

13.68 ± 3.54

PTT

30–40

35.15 ± 11.04

INR

0.8–1.1

1.18 ± 0.50

ALT (IU/L)

7–40

32 (22.25-51)

AST (IU/L)

0–45

52 (34–73)

LDH (IU/L)

114–240

640 (470–789)

Ferritin (µg/L)

11–330

494 (138–937)

ESR (mm/hr)

0–29

45 (25–58)

BS (mg/ml)

70–100

120 (102–163)

Urea (mg/mL)

6–24

45 (32.5–69.5)

Cr (mg/mL)

0.5–1.2

1.1 (0.90–1.50)

D.Dimer (mg/L)

0-0.5

0.64 (0.25–0.90)

ALP (IU/L)

44–147

183 (144–237)

Na (mEq/L)

135–145

140 (137–142)

K (mEq/L)

3.5–5.3

4.00 (3.80–4.60)

NLR

7.03 ± 5.52

PLR

201.08 ± 137.09

MLR

0.25 ± 0.22

dNLR

4.93 ± 3.20

NLPR

0.03 ± 0.02

SIRI

1.72 ± 1.66

SII

1419 ± 1112

AISI

349.00 ± 340.62

Severity

-

 Moderate, N (%)

 Severe, N (%)

 Very severe, N (%)

107 (63.3)

19 (11.2)

43 (25.4)

Comorbidities

-

Cardiovascular Disease (%)

Kidney Disease (%)

Diabetes (%)

Cancer (%)

Liver (%)

30.8

7.7

29.6

3.0

1.8

Charlson Comorbidity index

4.30 ± 1.77

Outcome

 Survival, N (%)

 Death, N (%)

-

123 (72.8)

46 (27.2)